Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/4200
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNazarova Nigina Otabek qizi-
dc.date.accessioned2026-06-10T06:04:20Z-
dc.date.available2026-06-10T06:04:20Z-
dc.date.issued2025-
dc.identifier.urihttp://repo.tma.uz/xmlui/handle/1/4200-
dc.description.abstractCardiovascular diseases remain the leading cause of morbidity and mortality worldwide, with atherosclerosis being a major underlying pathology. Among the various manifestations of atherosclerosis, atherosclerotic renal artery disease (ARAD) is of particular clinical importance due to its association with renovascular hypertension, chronic kidney disease (CKD), and an increased risk of cardiovascular events. Despite advancements in diagnostic and therapeutic approaches, ARAD often progresses silently and is frequently diagnosed at advanced stages, making early identification of risk factors crucial.en_US
dc.language.isoen_USen_US
dc.publisherO'zbekiston, Toshkent (TIBBIYOT FANLARINING DOLZARB MASALALARI) jurnali № 6en_US
dc.subjectchronic kidney disease, renal artery atherosclerosis, APOE, gene, polymorphism.en_US
dc.titleTHE ROLE OF APOLIPOPROTEIN E IN ATHEROSCLEROTIC RENAL ARTERY DISEASEen_US
dc.typeArticleen_US
Appears in Collections:

Files in This Item:
File Description SizeFormat 
6_THE_ROLE_OF_APOLIPOPROTEIN_E_IN_ATHEROSCLEROTIC_RENAL_ARTERY_DISEASE.pdf526.34 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.